Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile;Seroprevalencia de anticuerpos IgG contra parvovirus B19 en donantes de sangre de hospitales en Santiago, Chile

Revista Medica de Chile

Volumn 135, Issue 4, 2007, Pages 443-448

  Gaggero, Aldo ^a   Rivera, Joselin ^a   Calquín, Elizabeth ^a   Larrañaga, Carmen E ^a   León, Oscar ^a   Díaz, Patricia ^a   Gaggero, Nicolás ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Blood donors; Immunoglobulin G; Parvovirus B19, human

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD; BLOOD DONOR; CHILE; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; PARVOVIRUS; REPRODUCIBILITY; SEX RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; ANTIBODIES, VIRAL; BLOOD DONORS; CHILE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; REPRODUCIBILITY OF RESULTS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION;

EID: 34249032482     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. HEEGAARD ED, BROWN KE. Human Parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505.
2. YOUNG NS, BROWN KE. Parvovirus B19. N Engl J Med 2004; 350: 586-97.
3. CORCORAN A, DOYLE S. Advances in the biology, diagnosis and host-pathogen interactions of Parvovirus B19. J Med Microbiol 2004; 53: 459-75.
4. ANDERSON MJ, LEWIS E, KIDD IM, HALL SM, COHEN BJ. An outbreak of erythema infectiosum associated with human Parvovirus infection. J Hyg (London) 1984; 93: 85-93.
5. YAMASHITA K, MATSUNAGA Y, TAYLOR- WIEDEMAN J, YAMAZAKI S. A significant age shift of the human Parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jap J Med Sci Biol 1992; 45: 49-58.
6. COHEN BJ, BUCKLEY MM. The prevalence of antibody to human Parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-3.
7. ANDERSON LJ, TSOU C, PARKER RA, CHORBA TL, WULFF H, TATTERSALL P ET AL. Detection of antibodies and antigens of human Parvovirus B19 by enzyme linked immunoabsorbent assay. J Clin Microbiol 1986; 24: 522-6.
8. NASCIMENTO JP, BUCKLEY MM, BROWN KE, COHEN BJ. The prevalence of antibody to human Parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 1990; 32: 41-5.
9. ABARCA K, COHEN BJ, VIAL P. Seroprevalence of Parvovirus B19 in urban Chilean children and young adults, 1990 and 1996. Epidemiol Infect 2002; 128: 59-62.
10. ANDERSON LJ. Role of Parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711-8.
11. COUROUCE AM, FERCHAL F, MORINET F, MULLER A, DROUET J, SOULIER JP ET AL. Human parvovirus infections in France. Lancet 1984; 1: 160.
12. NUNOUE T, OKOCHI K, MORTIMER PP, COHEN BJ. Human parvovirus (B19) and erythema infectiosum. J Pediatr 1985; 107: 38-40.
13. TOLFVENSTAM T, ENBOM M, GHEBREKIDAN H, RUDEN U, LINDE A, GRANDIEN M ET AL. Seroprevalence of viral childhood infections in Eritrea. J Clin Virol 2000; 16: 49-54.
14. LIN KH, YOU SL, CHEN CJ, WANG CF, YANG CS, YAMAZAKI S. Seroepidemiology of human Parvovirus B19 in Taiwan. J Med Virol 1999; 57: 169-73.
15. DE FREITAS RB, WONG D, BOSWELL F, DE MIRANDA MF, LINHARES AC, SHIRLEY J ET AL. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J Med Virol 1990; 32: 203-8.
16. MANARESI E, GALLINELLA G, MORSELLI LABATE AM, ZUCCHELLI P, ZACCARELLI D, AMBRETTI S ET AL. Seroprevalence of IgG against conformational and linear capsid antigens of Parvovirus B19 in Italian blood donors. Epidemiol Infect 2004; 132: 857-62.
17. KELLY HA, SIEBERT D, HAMMOND R, LEYDON J, KIELY P, MASKILL W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000; 124: 449-57.
18. WEIMER T, STREICHERT S, WATSON C, GRONER A. Hightiter screening PCR: a successful strategy for reducing the Parvovirus B19 load in plasma pools for fractionations. Transfusion 2001; 41: 1500-4.
19. HITZLER WE, RUNKEL S. Prevalence of human Parvovirus B19 in blood donors as determined by a haemagglutination assay and verified by the polymerase chain reaction. Vox Sang 2002; 82: 18-23.
20. THOMAS I, DI GIAMBATTISTA M, GERARD C, MATHYS E, HOUGARDY V, LATOUR B ET AL. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 2003; 84: 300-7.
21. DURIGON EL, ERDMAN DD, GARY GW, PALLANSCH MA, TOROK TJ, ANDERSON LJ. Multiple primer pairs for Polymerase chain reaction (PCR) amplification of human Parvovirus B19 DNA. J Virol Methods 1993; 44: 155-65.
22. JORDAN J, TIANGCO B, KISS J, KOCH W. Human Parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 1998; 75: 97-102.
23. WAKAMATSU C, TAKAKURA F, KOJIMA E, KIRIYAMA Y, GOTO N, MATSUMOTO K ET AL. Screening of blood donors for human Parvovirus B19 and characterization of the results. Vox Sang 1999; 76: 14-2.
24. TSUJIMURA M, MATSUSHITA K, SHIRAKI H, SATO H, OKOCHI K, MAEDA Y. Human Parvovirus B19 infection in blood donors. Vox Sang 1995; 69: 206-12.
25. CANDOTTI D, ETIZ N, PARSYAN A, ALLAIN JP. Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples. J Virol 2004; 23: 12169-78.